Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Bioanalysis in the department has traditionally focused on anti-malaria drugs, with more than 20 bioanalytical methods in use currently. We have broadened the scope of applications to include a variety of antibiotics, antiviral and anti-parasitic drugs. Besides anti-tuberculosis drugs, we have validated and implemented methods for ivermectin and ceftriaxone into routine bioanalysis. Particular focus has been directed towards developing assays for field-adapted pharmacokinetic sampling methodologies (i.e. capillary blood spot assays).